文献速递关节外科

局部万古霉素粉末与稀释聚维酮碘冲洗方案对人工关节置换术后假体周围感染病原谱的影响

Does the Organism Profile of Periprosthetic Joint Infections Change With a Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Protocol?
PubMed 文献 · J Arthroplasty · 2020-12-26

该回顾性队列研究比较了实施局部万古霉素粉末与稀释聚维酮碘冲洗(VIP)方案前后初次全关节置换术(TJA)后90天内假体周围感染(PJI)的病原谱。共纳入18,299例TJA,发现VIP方案后凝固酶阴性葡萄球菌PJI的总体和相对发生率显著下降,而MSSA PJI相对发生率显著上升,全髋关节置换PJI病原谱无变化。结论认为VIP方案未导致更难治疗的PJI。

要点

  • VIP方案后凝固酶阴性葡萄球菌PJI总体发生率从0.20%降至0.04%。
  • VIP方案后MSSA PJI相对发生率从18.75%升至40.85%。
  • 全膝关节置换中MRSA PJI总体发生率显著降低。

核心结论

  • VIP方案与初次TJA后PJI病原谱变化相关,但未导致更难治疗的PJI。
  • 研究结果需前瞻性随机对照试验确认。

研究设计与样本

  • 回顾性队列研究,证据等级III级。
  • 纳入大学附属非营利骨科医院2012年1月至2013年12月(VIP前)和2016年1月至2019年12月(VIP后)的18,299例初次TJA。
  • 依据MSIS指南识别术后90天内的深部PJI。

主要发现

  • 共识别103例TJA PJI(VIP前32/3982,VIP后71/14,317)。

关键数值与推荐

  • PJI定义依据MSIS指南,发生于指数关节置换术后90天内。

临床怎么用

  • VIP方案可用于降低初次TJA后凝固酶阴性葡萄球菌和MRSA PJI发生率。
  • 临床需关注VIP方案后MSSA PJI相对比例上升的可能性。

局限性

  • 回顾性研究设计,证据等级III级。
  • 作者指出需要前瞻性随机对照试验确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While vancomycin powder and dilute povidone-iodine (VIP) is associated with fewer total joint arthroplasty (TJA) periprosthetic joint infections (PJI), its effect on PJI organism profiles is unclear. This study evaluates primary TJA PJI organism profiles before and after the implementation of a VIP protocol. METHODS: In total, 18,299 primary TJAs performed at a university-affiliated, not-for-profit orthopedic hospital from before (1/2012-12/2013) and after (1/2016-12/2019) a VIP protocol was initiated were reviewed to identify deep PJIs that occurred within 90 days of the index arthroplasty as defined by the Musculoskeletal Infection Society guidelines. Demographics, overall organism incidence (n/TJAs), and relative organism incidence (n/PJIs) from the two cohorts were compared. RESULTS: In total, 103 TJA PJIs were identified (pre-VIP: 32/3982; VIP: 71/14,317). Following the introduction of VIP, the overall and relative incidence of coagulase-negative staphylococcal TJA PJIs significantly decreased (overall: 0.20% to 0.04%, P = .004; relative: 25.00% to 8.45%, P = .031). In response, the relative incidence of MSSA TJA PJIs significantly increased (18.75% to 40.85%, P = .042). Broken down by arthroplasty type, VIP was associated with a significantly lower overall incidence of coagulase-negative staphylococcal total knee arthroplasty (TKA) PJIs (0.27% to 0.06%, P = .015), a significantly lower overall incidence of MRSA TKA PJIs (0.18% to 0.03%, P = .031), and a nonsignificant decrease in the overall incidence of gram-negative TKA PJIs (0.18% to 0.04%, P = .059). No organism profile changes were found in total hip arthroplasty PJIs. CONCLUSION: VIP is not associated with more difficult to treat primary TJA PJIs. While promising, these findings require a prospective randomized controlled trial for confirmation. LEVEL OF EVIDENCE: Level III, Retrospective cohort study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Buchalter DB, Teo GM, Kirby DJ, et al. Does the Organism Profile of Periprosthetic Joint Infections Change With a Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Protocol? J Arthroplasty. 2020. PMID: 33526397. doi:10.1016/j.arth.2020.12.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。